New Pill Could Reduce Risk of Hospitalization, Death From COVID-19, But Experts Say Vaccines Remain Best Tool

Post Date: 
WJC 13

“There’s people getting their first dose today,” said Dr. Kathleen Page, infectious disease physician and faculty at the Johns Hopkins School of Medicine. “So that’s fantastic.”

In Baltimore, COVID-19 ambassadors with the Johns Hopkins School of Medicine have been hard at work targeting the Latino community.

“I think it’s important to be where the community is, to meet people where they are,” Page said.

So far, over 107,000 Marylanders have received booster shots, and there’s been a sharp rise in the daily first and second doses administered over the past two days.